SCHEMBL9718839

SCHEMBL9718839

Clc1ccc(C2=C3C=CC(=N3)C(c3ccc(Cl)cc3)=C3C=CC(=N3)C(c3ccc(Cl)cc3)=C3C=CC(=N3)C(c3ccc(Cl)cc3)=C3C=CC2=N3)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ CYP2A6 P11509 1/20 0.35
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NOTUM Q6P988 3/20 0.32
▸ POLB P06746 1/20 0.32
▸ PTPN11 Q06124 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ GFER P55789 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ RPA1 P27694 1/20 0.31
▸ METAP2 P50579 1/20 0.31
▸ GCGR P47871 1/20 0.31
▸ CCNB2 O95067 1/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ CCNB1 P14635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL499291 0.78 ESR1 (0.42) LMNANPC1RAB9APOLBKDM4E
SCHEMBL9718812 0.78 HPGD (0.38) LMNANPC1RAB9ANOTUMPOLB
SCHEMBL3424113 0.78 ALDH1A1 (0.42) NPC1RAB9AGFERKDM4EGAA
SCHEMBL9429404 0.78 RAB9A (0.37) LMNANPC1RAB9ANOTUMKDM4E
SCHEMBL245938 0.76 MAPT (0.43) CYP1A2LMNANPC1RAB9ANOTUM
SCHEMBL14562749 0.76 ALDH1A1 (0.35) LMNANPC1RAB9ANOTUMKDM4E
SCHEMBL7996476 0.76 ALDH1A1 (0.35) LMNANPC1RAB9ANOTUMKDM4E
SCHEMBL2517442 0.76 ALDH1A1 (0.35) LMNANPC1RAB9ANOTUMKDM4E
SCHEMBL17554265 0.74 CA2 (0.42) KDM4E
SCHEMBL1680192 0.74 ME2 (0.43) LMNANPC1RAB9ABACE1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5103027-A Catalyst selectivity ARCO CHEMICAL TECHNOLOGY, L.P. (US) 1992-04-07 — — US claimed
EP-3419977-B1 PLATINUM(II) RING-FUSED CHLORINS, METHODS AND USES THEREOF UNIV DE COIMBRA (PT) 2024-01-03 — — EP disclosed
US-11420991-B2 Confined porphyrin Co(II) and preparation method and application thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2022-08-23 — — US disclosed
US-20210155650-A1 CONFINED PORPHYRIN CO(II) AND PREPARATION METHOD AND APPLICATION THEREOF ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2021-05-27 — — US disclosed
EP-3419977-A1 PLATINUM(II) RING-FUSED CHLORINS, METHODS AND USES THEREOF Universidade de Coimbra (PT) 2019-01-02 — — EP disclosed
WO-2017145092-A1 PLATINUM(II) RING-FUSED CHLORINS, METHODS AND USES THEREOF UNIVERSIDADE DE COIMBRA (PT) 2017-08-31 — — WO disclosed
US-5103027-A Catalyst selectivity ARCO CHEMICAL TECHNOLOGY, L.P. (US) 1992-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11420991-B2 Confined porphyrin Co(II) and preparation method and application thereof PPOX, PPIF, PPIC CYP1A2 147/4885LMNA 2391/4885CYP2A6 666/4885
US-20210155650-A1 CONFINED PORPHYRIN CO(II) AND PREPARATION METHOD AND APPLICATION THEREOF PPOX, PPIF, PPIC CYP1A2 147/4885LMNA 2391/4885CYP2A6 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback